Photronics Reports Second Quarter Fiscal 2025 Results and Announces CEO Transition
“I would like to thank Frank for leading Photronics over the past three years as CEO,” said
Commenting on the second-quarter performance,
Second Quarter Fiscal 2025 Results
- Revenue was
$211.0 million , down 3% year-over-year and 1% sequentially. - GAAP Net income attributable to
Photronics, Inc. shareholders was$8.9 million , or$0.15 per diluted share, compared with$36.3 million , or$0.58 per diluted share, in the second quarter of 2024 and$42.9 million , or$0.68 per diluted share, in the first quarter of 2025. - Non-GAAP Net income attributable to
Photronics, Inc. shareholders was$24.3 million , or$0.40 per diluted share, compared with$28.7 million , or$0.46 per diluted share in the second quarter of 2024 and$32.4 million , or$0.52 per diluted share, in the first quarter of 2025. - IC revenue was
$155.9 million , down 3% year-over-year and up 1% sequentially. - FPD revenue was
$55.1 million , down 2% from the same quarter last year and 5% sequentially. - Cash generated from operating activities was
$31.5 million , cash invested in organic growth through capital expenditures was$60.5 million , and cash returned to shareholders through share repurchases was$72.1 million . - Cash, cash equivalents and short-term investments at the end of the quarter was
$558.4 million .
Third Quarter Fiscal 2025 Guidance
For the third quarter of fiscal 2025, Photronics expects Revenue to be between
Webcast
A webcast to discuss these results is scheduled for
About Photronics
Photronics is a leading worldwide manufacturer of integrated circuit (IC) and flat panel display (FPD) photomasks. High precision quartz plates that contain microscopic images of electronic circuits, photomasks are a key element in the IC and FPD manufacturing process. Founded in 1969, Photronics has been a trusted photomask supplier for over 55 years. The company operates 11 strategically located manufacturing facilities in
Forward-Looking Statements
Certain statements in this press release constitute “forward-looking statements” regarding our industry, our strategic position, and our financial and operating results. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results, performance or achievements to differ materially. Please refer to our Annual Report on Form 10-K for the fiscal year ended
Non-GAAP Financial Measures
Non-GAAP Net Income attributable to
| Condensed Consolidated Statements of Income |
||||||||||||||||||||||
| (in thousands, except per share amounts) |
||||||||||||||||||||||
| (Unaudited) |
||||||||||||||||||||||
| Three Months Ended | Six Months Ended | |||||||||||||||||||||
| 2025 | 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||
| Revenue | $ | 210,992 | $ | 212,138 | $ | 217,000 | $ | 423,130 | $ | 433,334 | ||||||||||||
| Cost of goods sold | 133,086 | 136,603 | 137,749 | 269,689 | 274,828 | |||||||||||||||||
| Gross Profit | 77,906 | 75,535 | 79,251 | 153,441 | 158,506 | |||||||||||||||||
| Gross margin % | 36.9% | 35.6% | 36.5% | 36.3% | 36.6% | |||||||||||||||||
| Operating Expenses: | ||||||||||||||||||||||
| Selling, general and administrative | 18,099 | 19,101 | 18,996 | 37,201 | 37,317 | |||||||||||||||||
| Research and development | 4,090 | 4,257 | 4,292 | 8,346 | 7,736 | |||||||||||||||||
| Total Operating Expenses | 22,189 | 23,358 | 23,288 | 45,547 | 45,053 | |||||||||||||||||
| Other operating gain | - | - | 89 | - | 89 | |||||||||||||||||
| Operating Income | 55,717 | 52,177 | 56,052 | 107,894 | 113,542 | |||||||||||||||||
| Operating Margin | 26.4% | 24.6% | 25.8% | 25.5% | 26.2% | |||||||||||||||||
| Non-operating (loss) income, net | (25,786 | ) | 24,981 | 20,534 | (805 | ) | 16,786 | |||||||||||||||
| Income Before Income Tax Provision | 29,931 | 77,158 | 76,586 | 107,089 | 130,328 | |||||||||||||||||
| Income tax provision | 5,714 | 18,901 | 20,214 | 24,615 | 34,874 | |||||||||||||||||
| Net Income | 24,217 | 58,257 | 56,372 | 82,474 | 95,454 | |||||||||||||||||
| Net income attributable to noncontrolling interests | 15,356 | 15,406 | 20,121 | 30,762 | 33,023 | |||||||||||||||||
| Net income attributable to |
$ | 8,861 | $ | 42,851 | $ | 36,251 | $ | 51,712 | $ | 62,431 | ||||||||||||
| Earnings per share attributed to |
||||||||||||||||||||||
| Basic | $ | 0.15 | $ | 0.69 | $ | 0.59 | $ | 0.84 | $ | 1.01 | ||||||||||||
| Diluted | $ | 0.15 | $ | 0.68 | $ | 0.58 | $ | 0.84 | $ | 1.00 | ||||||||||||
| Weighted-average number of common shares outstanding: | ||||||||||||||||||||||
| Basic | 60,793 | 62,093 | 61,771 | 61,443 | 61,613 | |||||||||||||||||
| Diluted | 60,974 | 62,661 | 62,409 | 61,817 | 62,346 | |||||||||||||||||
| Condensed Consolidated Balance Sheets | |||||||||
| (in thousands) | |||||||||
| (Unaudited) | |||||||||
| 2025 | 2024 | ||||||||
| Assets | |||||||||
| Current assets: | |||||||||
| Cash and cash equivalents | $ | 530,708 | $ | 598,485 | |||||
| Short-term investments | 27,699 | 42,184 | |||||||
| Accounts receivable | 195,977 | 200,830 | |||||||
| Inventories | 61,201 | 56,527 | |||||||
| Other current assets | 40,221 | 33,036 | |||||||
| Total current assets | 855,806 | 931,062 | |||||||
| Property, plant and equipment, net | 807,558 | 745,257 | |||||||
| Other assets | 39,668 | 35,740 | |||||||
| Total assets | $ | 1,703,032 | $ | 1,712,059 | |||||
| Liabilities and Equity | |||||||||
| Current liabilities: | |||||||||
| Current portion of long-term debt | $ | 11 | $ | 17,972 | |||||
| Accounts payable and accrued liabilities | 166,772 | 165,839 | |||||||
| Total current liabilities | 166,783 | 183,811 | |||||||
| Long-term debt | 19 | 25 | |||||||
| Other liabilities | 39,461 | 47,464 | |||||||
| Equity: | |||||||||
| 1,100,920 | 1,120,864 | ||||||||
| Noncontrolling interests | 395,849 | 359,895 | |||||||
| Total equity | 1,496,769 | 1,480,759 | |||||||
| Total liabilities and equity | $ | 1,703,032 | $ | 1,712,059 | |||||
| Condensed Consolidated Statements of Cash Flows | |||||||||||
| (in thousands) | |||||||||||
| (Unaudited) | |||||||||||
| Six Months Ended | |||||||||||
| 2025 | 2024 | ||||||||||
| Cash flows from operating activities: | |||||||||||
| Net income | $ | 82,474 | $ | 95,454 | |||||||
| Adjustments to reconcile net income to net cash | |||||||||||
| provided by operating activities: | |||||||||||
| Depreciation and amortization | 40,386 | 41,487 | |||||||||
| Share-based compensation | 6,710 | 6,499 | |||||||||
| Changes in operating assets, liabilities and other | (19,651 | ) | (25,446 | ) | |||||||
| Net cash provided by operating activities | 109,919 | 117,994 | |||||||||
| Cash flows from investing activities: | |||||||||||
| Purchases of property, plant and equipment | (95,749 | ) | (63,311 | ) | |||||||
| Purchases of short-term investments | (27,689 | ) | (66,040 | ) | |||||||
| Proceeds from maturities of short-term investments | 41,482 | 13,234 | |||||||||
| Government incentives | 1,166 | 1,419 | |||||||||
| Other | (57 | ) | (6 | ) | |||||||
| Net cash used in investing activities | (80,847 | ) | (114,704 | ) | |||||||
| Cash flows from financing activities: | |||||||||||
| Repayments of debt | (17,966 | ) | (2,844 | ) | |||||||
| Common stock repurchases | (76,682 | ) | - | ||||||||
| Proceeds from share-based arrangements | 1,583 | 1,055 | |||||||||
| Net settlements of restricted stock awards | (2,007 | ) | (2,938 | ) | |||||||
| Net cash used in financing activities | (95,072 | ) | (4,727 | ) | |||||||
| Effects of exchange rate changes on cash, cash equivalents, and restricted cash | (1,697 | ) | (3,839 | ) | |||||||
| Net decrease in cash, cash equivalents, and restricted cash | (67,697 | ) | (5,276 | ) | |||||||
| Cash, cash equivalents, and restricted cash, beginning of period | 601,243 | 501,867 | |||||||||
| Cash, cash equivalents, and restricted cash, end of period | $ | 533,546 | $ | 496,591 | |||||||
| Reconciliation of GAAP Net income and Earnings per Share attributable to |
|||||||||||
| (in thousands, except per share amounts) | |||||||||||
| (Unaudited) | |||||||||||
| Three Months ended | |||||||||||
| 2025 | 2025 | 2024 | |||||||||
| GAAP Net income attributable to |
$ | 8,861 | $ | 42,851 | $ | 36,251 | |||||
| FX (gain) loss | 31,111 | (18,443 | ) | (14,766 | ) | ||||||
| Estimated tax effects of FX (gain) loss | (8,337 | ) | 5,152 | 3,743 | |||||||
| Estimated noncontrolling interest effects of above | (7,376 | ) | 2,823 | 3,489 | |||||||
| Non-GAAP Net income attributable to |
$ | 24,259 | $ | 32,383 | $ | 28,717 | |||||
| Weighted-average number of common shares outstanding - Diluted | 60,974 | 62,661 | 62,409 | ||||||||
| GAAP Diluted earnings per share attributable to |
$ | 0.15 | $ | 0.68 | $ | 0.58 | |||||
| Effects of non-GAAP adjustments above | 0.25 | (0.16 | ) | (0.12 | ) | ||||||
| Non-GAAP Diluted earnings per share attributable to |
$ | 0.40 | $ | 0.52 | $ | 0.46 | |||||
For Further Information:
VP, Investor Relations
469.395.8175
tmoreau@photronics.com
Source: Photronics, Inc.




